GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

“It can now take up to 15 years to bring a new medicine to market, as the science and the manufacturing are so complex,” explains Alix Mackay, Director of Pharma Business Development at the innovation ...